MYC and neoplasm: Moreover, FAO is highly upregulated in MYC-overexpressing triple-negative breast cancer (TNBC), and treatment with FAO inhibitors such as etomoxir effectively impairs tumor growth, suggesting that FAO inhibition represents a potential therapeutic strategy for TNBC [227].